22.94
-3.06 (-11.77%)
| Penutupan Terdahulu | 26.00 |
| Jumlah Dagangan | 40,557,342 |
| Harga / Pendapatan (P/E Ke hadapan) | 67.53 |
| Harga / Jualan (P/S) | 2.49 |
| Harga / Buku (P/B) | 18.72 |
| Julat 52 Minggu |
| Margin Keuntungan | 9.21% |
| Margin Operasi (TTM) | 10.12% |
| EPS Cair (TTM) | 0.680 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 110.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 344.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 11.54% |
| Nisbah Semasa (MRQ) | 1.59 |
| Aliran Tunai Operasi (OCF TTM) | 334.34 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 213.45 M |
| Pulangan Atas Aset (ROA TTM) | 10.76% |
| Pulangan Atas Ekuiti (ROE TTM) | 36.79% |
AISkor Stockmoo
| Nilai 30% | 0.0 |
| AI Insight info | NA |
| Penilaian Relatif info | -2.2 |
| Kesihatan Kewangan info | 3.4 |
| Masa 30% | -2.5 |
| AI Technical info | NA |
| Osilator Teknikal info | -2.5 |
| Purata Bergerak Teknikal info | -2.5 |
| Sentimen 20% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Sentimen Berita info | NA |
| Wang Pintar 20% | 0.0 |
| Aktiviti Orang Dalam info | 0.0 |
| Aliran Institusi info | NA |
| Persekitaran | ×1.15 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -4.0% |
| Persetujuan Tonggak | ×1.00 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 4.4 |
| Skor Akhir | -0.85 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Hims & Hers Health, Inc. | Bercampur | Menurun |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| HIMS | - | - | - | 18.72 |
| RDY | - | 0.68% | - | 3.07 |
| TAK | - | 4.61% | - | 1.43 |
| HLN | - | 2.14% | - | 1.84 |
| TEVA | - | - | - | 6.23 |
| ZTS | - | 2.81% | - | 10.19 |
|
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 11.13% |
| % Dimiliki oleh Institusi | 82.47% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 18 Aug 2026 | CNBC | Hims & Hers CEO says FTC lawsuit misunderstands how the company works |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |